{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T05:44:13Z","timestamp":1740894253182,"version":"3.38.0"},"reference-count":29,"publisher":"Pan African Medical Journal","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pan Afr Med J"],"DOI":"10.11604\/pamj.2024.49.87.43958","type":"journal-article","created":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T13:25:36Z","timestamp":1740835536000},"source":"Crossref","is-referenced-by-count":0,"title":["Risk factors for rifampicin resistance tuberculosis among patients attending Directly Observed Treatments Centres in Southwestern Nigeria"],"prefix":"10.11604","volume":"49","author":[{"given":"Simeon","family":"Cadmus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor Oluwatoyin","family":"Akinseye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Temitayo","family":"Olagunju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Makolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olutayo","family":"Falodun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oluwole","family":"Lawal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Babalola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eniola","family":"Cadmus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Othman","family":"Yasir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muse","family":"Fadeyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bolaji","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Piubello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nimer","family":"Ortuno Guiterrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osman","family":"El-Tayeb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4870","published-online":{"date-parts":[[2024]]},"reference":[{"key":"ref1","article-title":"Global Tuberculosis Report 2022","author":"World Health Organization","year":"2022","unstructured":"1. World Health Organization, Global Tuberculosis Report 2022, Geneva:World Health Organization, 2022;Accessed 15th May 2024"},{"issue":"7","key":"ref2","doi-asserted-by":"crossref","first-page":"e1001064","DOI":"10.1371\/journal.pmed.1001064","article-title":"GenXpert-a game changer for tuberculosis control?","volume":"8","author":"Evans CA","year":"2011","unstructured":"2. Evans CA, GenXpert-a game changer for tuberculosis control?, PLoS Med, 2011;8(7):e1001064","journal-title":"PLoS Med"},{"key":"ref3","first-page":"4091937","article-title":"Diagnostic Yield of Fluorescence and Ziehl-Neelsen Staining Techniques in the Diagnosis of Pulmonary Tuberculosis: A Comparative Study in a District Health Facility","volume":"10","author":"Dzodanu EG, Afrifa J, Acheampong DO, Dadzie I","year":"2019","unstructured":"3. Dzodanu EG, Afrifa J, Acheampong DO, Dadzie I, Diagnostic Yield of Fluorescence and Ziehl-Neelsen Staining Techniques in the Diagnosis of Pulmonary Tuberculosis: A Comparative Study in a District Health Facility, Tuberc Res Treat, 2019;104091937","journal-title":"Tuberc Res Treat"},{"key":"ref4","article-title":"Global tuberculosis control: WHO report 2011","author":"World Health Organization","year":"2011","unstructured":"4. World Health Organization, Global tuberculosis control: WHO report 2011, 2011;Accessed 15th May, 2024"},{"key":"ref5","article-title":"Implementing tuberculosis diagnostics: A policy framework","author":"World Health Organization","year":"2019","unstructured":"5. World Health Organization, Implementing tuberculosis diagnostics: A policy framework, 2019;"},{"issue":"1","key":"ref6","first-page":"7","article-title":"Updated guidelines for the use of nucleic acid amplification tests in the diagnosis of tuberculosis","volume":"58","author":"Centers for Disease Control and Prevention (CDC)","year":"2009","unstructured":"6. Centers for Disease Control and Prevention (CDC), Updated guidelines for the use of nucleic acid amplification tests in the diagnosis of tuberculosis, MMWR Morb Mortal Wkly Rep, 2009;58(1):7-10","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"9776","key":"ref7","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0140-6736(11)60438-8","article-title":"Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB\/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicenter implementation study","volume":"377","author":"Boehme CC, Nicol MP, Nabeta P, Michael JS, Gotuzzo E, Tahirli R","year":"2011","unstructured":"7. Boehme CC, Nicol MP, Nabeta P, Michael JS, Gotuzzo E, Tahirli R, Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB\/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicenter implementation study, Lancet, 2011;377(9776):1495-505","journal-title":"Lancet"},{"issue":"11","key":"ref8","doi-asserted-by":"crossref","first-page":"e1001120","DOI":"10.1371\/journal.pmed.1001120","article-title":"Rapid diagnosis of tuberculosis with the Xpert MTB\/RIF assay in high burden countries: a cost-effectiveness analysis","volume":"8","author":"Vassall A, van Kampen S, Sohn H, Michael JS, John K, den Boon S","year":"2011","unstructured":"8. Vassall A, van Kampen S, Sohn H, Michael JS, John K, den Boon S, Rapid diagnosis of tuberculosis with the Xpert MTB\/RIF assay in high burden countries: a cost-effectiveness analysis, PLoS Med, 2011;8(11):e1001120","journal-title":"PLoS Med"},{"key":"ref9","article-title":"Global tuberculosis report 2020","author":"World Health Organization","year":"2020","unstructured":"9. World Health Organization, Global tuberculosis report 2020, Geneva, Switzerland:WHO, 2020;Accessed 15th May, 2024"},{"issue":"11","key":"ref10","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa0907847","article-title":"Rapid molecular detection of tuberculosis and rifampin resistance","volume":"363","author":"Boehme CC, Nabeta P, Hillemann D, Nicol MP, Shenai S, Krapp F","year":"2010","unstructured":"10. Boehme CC, Nabeta P, Hillemann D, Nicol MP, Shenai S, Krapp F, Rapid molecular detection of tuberculosis and rifampin resistance, N Engl J Med, 2010;363(11):1005-15","journal-title":"N Engl J Med"},{"key":"ref11","unstructured":"11. Oyo State Government, Accessed 10th August 2023","journal-title":"Oyo State Government"},{"key":"ref12","unstructured":"12. Definitions and reporting framework for tuberculosis - 2013 revision (updated December 2014 and January 2020), Accessed 12th September 2023","journal-title":"Definitions and reporting framework for tuberculosis - 2013 revision (updated December 2014 and January 2020)"},{"key":"ref13","year":"2012","unstructured":"13. Cepheid GeneXpert Dx System Users\u00b4 manual, 2012;","journal-title":"Cepheid GeneXpert Dx System Users\u00b4 manual"},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1186\/s12879-019-4241-7","article-title":"Prevalence of tuberculosis, multidrug resistant tuberculosis and associated risk factors among smear negative presumptive pulmonary tuberculosis patients in Addis Ababa, Ethiopia","volume":"19","author":"Sinshaw W, Kebede A, Bitew A, Tesfaye E, Tadesse M, Mehamed Z","year":"2019","unstructured":"14. Sinshaw W, Kebede A, Bitew A, Tesfaye E, Tadesse M, Mehamed Z, Prevalence of tuberculosis, multidrug resistant tuberculosis and associated risk factors among smear negative presumptive pulmonary tuberculosis patients in Addis Ababa, Ethiopia, BMC Infect Dis, 2019;19(1):641","journal-title":"BMC Infect Dis"},{"issue":"2","key":"ref15","first-page":"805","article-title":"Mult-drug resistant Mycobacterium tuberculosis in Port Harcourt, Nigeria","volume":"7","author":"Otokunefor K, Otokunefor TV, Omakwele G","year":"2018","unstructured":"15. Otokunefor K, Otokunefor TV, Omakwele G, Mult-drug resistant Mycobacterium tuberculosis in Port Harcourt, Nigeria, Afr J Lab Med, 2018;7(2):805","journal-title":"Afr J Lab Med"},{"issue":"7","key":"ref16","doi-asserted-by":"crossref","first-page":"e02096","DOI":"10.1016\/j.heliyon.2019.e02096","article-title":"Rifampicin resistance among notified pulmonary tuberculosis (PTB) cases in South-Southern Nigeria","volume":"5","author":"Ukwamedua H, Omote V, Etaghene J, Oseji ME, Agwai IC, Agbroko H","year":"2019","unstructured":"16. Ukwamedua H, Omote V, Etaghene J, Oseji ME, Agwai IC, Agbroko H, Rifampicin resistance among notified pulmonary tuberculosis (PTB) cases in South-Southern Nigeria, Heliyon, 2019;5(7):e02096","journal-title":"Heliyon"},{"issue":"1","key":"ref17","first-page":"39","article-title":"Multidrug resistant Mycobacterium tuberculosis in Adamawa State, Nigeria","volume":"13","author":"Omisore NO, Oyewole MO, Akinkunmi EO","year":"2018","unstructured":"17. Omisore NO, Oyewole MO, Akinkunmi EO, Multidrug resistant Mycobacterium tuberculosis in Adamawa State, Nigeria, Afr J Infect Dis, 2018;13(1):39-47","journal-title":"Afr J Infect Dis"},{"issue":"1","key":"ref18","first-page":"88","article-title":"Characteristics of Mycobacterium Tuberculosis Positive Patients Screened for Drug-Resistant Tuberculosis at a Tertiary Health Facility in Lagos, Nigeria","volume":"110","author":"Kuyinu YA, Odugbemi BA, Salisu-Olatunji SO, Adepoju FO, Odusanya OO","year":"2018","unstructured":"18. Kuyinu YA, Odugbemi BA, Salisu-Olatunji SO, Adepoju FO, Odusanya OO, Characteristics of Mycobacterium Tuberculosis Positive Patients Screened for Drug-Resistant Tuberculosis at a Tertiary Health Facility in Lagos, Nigeria, J Natl Med Assoc, 2018;110(1):88-91","journal-title":"J Natl Med Assoc"},{"issue":"8","key":"ref19","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.4103\/njcp.njcp_192_19","article-title":"Multidrug-resistant tuberculosis in Imo State, Southeast, Nigeria","volume":"23","author":"E Ahiarakwem II, Ekejindu IM, Akujobi CN, Aghanya IN","year":"2020","unstructured":"19. E Ahiarakwem II, Ekejindu IM, Akujobi CN, Aghanya IN, Multidrug-resistant tuberculosis in Imo State, Southeast, Nigeria, Niger J Clin Pract, 2020;23(8):1172-1177","journal-title":"Niger J Clin Pract"},{"issue":"9","key":"ref20","doi-asserted-by":"crossref","first-page":"e0238007","DOI":"10.1371\/journal.pone.0238007","article-title":"A descriptive study of smear negative pulmonary tuberculosis in a high HIV burden patient\u00b4s population in North Central Nigeria","volume":"15","author":"Tiamiyu AB, Iliyasu G, Dayyab FM, Habib ZG, Tambuwal SH, Animashaun AO","year":"2020","unstructured":"20. Tiamiyu AB, Iliyasu G, Dayyab FM, Habib ZG, Tambuwal SH, Animashaun AO, A descriptive study of smear negative pulmonary tuberculosis in a high HIV burden patient\u00b4s population in North Central Nigeria, PLoS One, 2020;15(9):e0238007","journal-title":"PLoS One"},{"key":"ref21","first-page":"204","article-title":"Prevalence of rifampicin resistance by automated Genexpert rifampicin assay in patients with pulmonary tuberculosis in Yenagoa, Nigeria","volume":"29","author":"Ikuabe PO, Ebuenyi ID","year":"2018","unstructured":"21. Ikuabe PO, Ebuenyi ID, Prevalence of rifampicin resistance by automated Genexpert rifampicin assay in patients with pulmonary tuberculosis in Yenagoa, Nigeria, Pan African Medical Journal, 2018;29204","journal-title":"Pan African Medical Journal"},{"issue":"9","key":"ref22","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.3855\/jidc.12736","article-title":"Rifampicin resistance patterns and dynamics of tuberculosis and drug-resistant tuberculosis in Enugu, South Eastern Nigeria","volume":"14","author":"Ugwu KO, Onah IS, Mbah GC, Ezeonu IM","year":"2020","unstructured":"22. Ugwu KO, Onah IS, Mbah GC, Ezeonu IM, Rifampicin resistance patterns and dynamics of tuberculosis and drug-resistant tuberculosis in Enugu, South Eastern Nigeria, J Infect Dev Ctries, 2020;14(9):1011-1018","journal-title":"J Infect Dev Ctries"},{"issue":"7","key":"ref23","doi-asserted-by":"crossref","first-page":"e0180996","DOI":"10.1371\/journal.pone.0180996","article-title":"Prevalence of drug-resistant tuberculosis in Nigeria: A systematic review and meta-analysis","volume":"12","author":"Onyedum CC, Alobu I, Ukwaja KN","year":"2017","unstructured":"23. Onyedum CC, Alobu I, Ukwaja KN, Prevalence of drug-resistant tuberculosis in Nigeria: A systematic review and meta-analysis, PLoS One, 2017;12(7):e0180996","journal-title":"PLoS One"},{"issue":"3","key":"ref24","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3390\/microbiolres13030043","article-title":"Patterns of presentation of drug-resistant tuberculosis in Nigeria: a retrospective file review","volume":"13","author":"Oladimeji O, Othman Y, Oladimeji KE, Atiba BP, Adepoju VA, Odugbemi BA","year":"2022","unstructured":"24. Oladimeji O, Othman Y, Oladimeji KE, Atiba BP, Adepoju VA, Odugbemi BA, Patterns of presentation of drug-resistant tuberculosis in Nigeria: a retrospective file review, Microbiol Res, 2022;13(3):609-619","journal-title":"Microbiol Res"},{"issue":"6","key":"ref25","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1093\/jac\/42.6.735","article-title":"Susceptibility of multidrug-resistant strains of Mycobacterium tuberculosis to amoxycillin in combination with clavulanic acid and ethambutol","volume":"42","author":"Abate G, Mi\u00f6rner H","year":"1998","unstructured":"25. Abate G, Mi\u00f6rner H, Susceptibility of multidrug-resistant strains of Mycobacterium tuberculosis to amoxycillin in combination with clavulanic acid and ethambutol, J Antimicrob Chemother, 1998;42(6):735-40","journal-title":"J Antimicrob Chemother"},{"issue":"15","key":"ref26","first-page":"572","article-title":"Prevalence and drug resistance profile of Mycobacterium tuberculosis isolated from pulmonary tuberculosis patients attending two public hospitals in East Gojjam zone, northwest Ethiopia","volume":"20","author":"Adane K, Ameni G, Bekele S, Abebe M, Aseffa A","year":"2015","unstructured":"26. Adane K, Ameni G, Bekele S, Abebe M, Aseffa A, Prevalence and drug resistance profile of Mycobacterium tuberculosis isolated from pulmonary tuberculosis patients attending two public hospitals in East Gojjam zone, northwest Ethiopia, BMC Public Health, 2015;20(15):572","journal-title":"BMC Public Health"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2174\/1874306401610010029","article-title":"Patterns of Drug Resistance Among Tuberculosis Patients in West and Northwestern Iran","volume":"10","author":"Sahebi L, Ansarin K, Mohajeri P, Khalili M, Monfaredan A, Farajnia S","year":"2016","unstructured":"27. Sahebi L, Ansarin K, Mohajeri P, Khalili M, Monfaredan A, Farajnia S, Patterns of Drug Resistance Among Tuberculosis Patients in West and Northwestern Iran, Open Respir Med J, 2016;1029-35","journal-title":"Open Respir Med J"},{"issue":"3","key":"ref28","first-page":"308","article-title":"Prevalence of multidrug-resistant tuberculosis among newly diagnosed cases of sputum positive pulmonary tuberculosis","volume":"133","author":"Sharma SK, Kaushik G, Jha B, George N, Arora SK, Gupta D","year":"2011","unstructured":"28. Sharma SK, Kaushik G, Jha B, George N, Arora SK, Gupta D, Prevalence of multidrug-resistant tuberculosis among newly diagnosed cases of sputum positive pulmonary tuberculosis, Indian J Med Res, 2011;133(3):308-11","journal-title":"Indian J Med Res"},{"key":"ref29","first-page":"9","article-title":"Drug-Resistant Tuberculosis and HIV Infection: Current Perspectives","volume":"12","author":"Singh A, Prasad R, Balasubramanian V, Gupta N","year":"2020","unstructured":"29. Singh A, Prasad R, Balasubramanian V, Gupta N, Drug-Resistant Tuberculosis and HIV Infection: Current Perspectives, HIV AIDS (Auckl), 2020;129-31","journal-title":"HIV AIDS (Auckl)"}],"container-title":["The Pan African Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.panafrican-med-journal.com\/\/content\/article\/49\/87\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T13:27:23Z","timestamp":1740835643000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.panafrican-med-journal.com\/\/content\/article\/49\/87\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":29,"URL":"https:\/\/doi.org\/10.11604\/pamj.2024.49.87.43958","relation":{},"ISSN":["1937-8688"],"issn-type":[{"value":"1937-8688","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]}}}